HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

<p>Abstract</p> <p>Background</p> <p>The beneficial effects of early statin use in kidney transplant recipients, especially those on tacrolimus-based immunosuppression, are not well established. We evaluated the predictors of statin use following kidney transplantation...

Full description

Bibliographic Details
Main Authors:	Schaefer Heidi, Basu Amit, Tan Henkie, Johnston James, McCauley Jerry, Shapiro Ron, Wu Christine M, Younas Nizar, Smetanka Cynthia, Winkelmayer Wolfgang C, Unruh Mark
Format:	Article
Language:	English
Published:	BMC 2010-04-01
Series:	BMC Nephrology
Online Access:	http://www.biomedcentral.com/1471-2369/11/5

Similar Items

Effects of HMG-CoA Reductase Inhibitors (Statins) On Bone Mineral Density and Metabolism
by: Nehir Samancı, et al.
Published: (2004-06-01)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
by: Suetonia C. Palmer, et al.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
by: Suetonia C. Palmer, et al.

An Assessment of Oral Health in Hypertensive Patients Treated with HMG-CoA Reductase Inhibitors (Statins)
by: Amir AM Al-Joboury, et al.
Published: (2015-12-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
by: Shi-You Jiang, et al.
Published: (2018-12-01)

Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
by: Anna Markowska, et al.
Published: (2020-11-01)

Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01)

Activation of HMG-CoA reductase by microsomal phosphatase
by: K R Feingold, et al.
Published: (1983-03-01)

Regulation of HMG-CoA reductase activity in plants.
by: B A Stermer, et al.
Published: (1994-07-01)

The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
by: H J Harwood, Jr, et al.
Published: (1982-07-01)

Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
by: Sunita Upreti, et al.
Published: (2019-01-01)

Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study
by: Abraham Simatupang, et al.
Published: (2018-10-01)

Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis
by: McKay, Damian
Published: (2010)

Occupancy and function of the hepatic HMG-CoA reductase promoter
by: Lagor, William Raymond
Published: (2006)

The Regulation of HMG-CoA Reductase by Enzyme-Lipid Interactions
by: Smith, Vana L.
Published: (1981)

HMG CoA reductase of intestinal mucosa and liver of the rat
by: S. Shefer, et al.
Published: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
by: G.M.B. Berger, et al.
Published: (1998-05-01)

A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
by: Paula Mihaljević-Jurič, et al.
Published: (2021-06-01)

ASSOCIATION OF POLYMORPHISM RS3846663 IN HMG-CoA REDUCTASE GENE WITH THE EFFECTIVENESS OF STATIN THERAPY IN PATIENTS WITH CORONARY HEART DISEASE
by: Aleksey Vladimirovich Osedko, et al.
Published: (2019-05-01)

Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
by: Kuang-Hsing Chiang, et al.
Published: (2015-01-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
by: Noel Lorenzo Villalba, et al.
Published: (2021-06-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
by: Xuemei Li, et al.
Published: (2013-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
by: Paolo Gelosa, et al.
Published: (2007-11-01)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
by: DANIEL M. DUDA-SEIMAN, et al.
Published: (2011-01-01)

The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells
by: Kusuyama Takanori, et al.
Published: (2006-01-01)

The role of HMG-CoA reductase inhibitors in cardiovascular risk reduction
by: McIntyre, Christine
Published: (2004)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
by: Jobin Jean, et al.
Published: (2004-05-01)

The effect of cyclic monoterpenes upon HMG-Co.A reductase activity
by: Clegg, R. J.
Published: (1983)

Determination of HMG-CoA reductase inhibitors by micellar electrokinetic chromatography
by: Mircia Eleonora, et al.
Published: (2016-06-01)

Purification of HMG-CoA Reductase and Regulation by Protein-Lipid Interactions
by: Brent, Lynn G. (Lynn Gran)
Published: (1982)

Pharmacogenetic and environmental determinants of response to HMG-CoA reductase inhibitors.
Published: (2007)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
by: H J Harwood, Jr, et al.
Published: (1984-09-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
by: R Langdon, et al.
Published: (1977-01-01)

Diurnal variation of HMG CoA reductase activity in rat intestine
by: S. Shefer, et al.
Published: (1972-09-01)

NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (<it>Monascus spp</it>.) food supplements
by: Lachenmeier Dirk W, et al.
Published: (2012-03-01)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
by: Marc M Schumacher, et al.
Published: (2015-03-01)

Therapeutic Interchange Evaluation of HMG-CoA Reductase Inhibitors in Patients with Dyslipidemia
by: Lin, Hong-Yun, et al.
Published: (2006)

The effect of HMG CoA reductase inhibition on platelet and vascular reactivity in hypercholesterolaemia
by: Hughes, SineÌad Marie-TheÌreÌ€se
Published: (2006)